Participation to TERMIS EU 2025
TERMIS EU 2025 May 15th, 2025, Vienna, Austria Our co-founder, COO/CSO Regina Grillari is a selected speaker at Termis EU Congress
15
05, 2025
8
05, 2025
Participation to Cell Culture Days 2025
Cell Culture Days 2025 May 8th, 2025, Vienna, AustriaOur co-founder, COO/CSO Regina Grillari is an invited speaker at the Cell Culture Days
8
04, 2025
Participation to ISEV 2025
Meet us at ISEV2025 April 8th, 2025, Vienna, Austria Visit us at booth B13 at the ISEV 2025 meeting in Vienna,
21
10, 2024
Evercyte and TAmiRNA to highlight advances in EV characterization at Precision EV forum
Evercyte and TAmiRNA to highlight advances in EV characterization at Precision EV forum October 21st, 2024 - Vienna, AustriaWe, together with our
26
09, 2024
Participation to the ASEV and CzeSEV 2024 meeting
We participated to the ASEV and CzeSEV 2024 meeting in Vienna, Austria September 26th, 2024, Vienna, Austria We participated to the
23
05, 2024
hTERT immortalized ASC for large-scale EV production
Recent publication showcasing our ASC/TERT1 cells as EV production system May 23rd, 2024, Vienna, AustriaOur telomerized human adipose derived MSC (ASC/TERT1, also known in
22
11, 2023
Evercyte Showcases Expertise in Japan’s Pharma Landscape
Evercyte Showcases Expertise in Japan’s Pharma Landscape November 22nd, 2023, Vienna, Austria We recently visited Summit Pharmaceuticals International to present our
27
10, 2023
Participation to the first MOVE symposium
We participated to the first MOVE symposium in Malaga, Spain October 27th, 2023, Vienna, Austria We participated to the first MOVE
19
09, 2023
Participation to the Small New World 2.0 meeting
We participated to the Small New World 2.0 meeting in Graz, Austria September 12th, 2023, Vienna, Austria We participated to the
4
05, 2023
Participation in the CHANGE project
We are proud to announce our participation in the CHANGE project May 4th, 2023, Vienna, Austria The CHANGE project focuses on